# Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy

> **NCT05169060** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Iowa** · enrollment: 100 (estimated)

## Conditions studied

- Diabetic Neuropathies

## Interventions

- **DRUG:** Fish Oil Concentrate, 1000 Mg Oral Capsule
- **DRUG:** Salsalate Oral Tablet

## Key facts

- **NCT ID:** NCT05169060
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-06-12
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05169060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05169060, "Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05169060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*